TARABIOS

United StatesProfile 77%

Tarabios Develops Mobile Blood Coagulation Monitoring Platform for Point of Care and Self Care for patients who are having anticoagulants therapy

Problem

Blood coagulation time (PT) or simply its normalized ratio (INR) is expected to be between 0.8 and 1.2. Lower INR means faster clotting while higher INR means slower clotting. According to medical condition of some patients may require higher levels of INR. Hence frequent and regular testing is required to meet desired INR levels for patients on anti coagulation Therapy. Such frequent testing have a better chance to prevent; stroke, thrombosis and embolism and treat Deep Vein Thrombosis

Solution

Tarabios POC / SelfCare PT/INR Diagnostic Device for self-testing paltform:have Novel Fiber Optics based patented Mechanical Measurement System which is sensitive to viscosity changes ( clot and fibrin formation)

Want to connect with TARABIOS?

Sign up on StartupDeal to see the full profile, compare startups with AI and reach the team.

Join as an Ecosystem Partner →